Pediatric HIV infection: Diagnostic laboratory methods

Fetal and Pediatric Pathology

Volumn 25, Issue 5, 2006, Pages 249-260

  Lujan Zilbermann, Jorge ^a,b   Rodriguez, Carina A ^a   Emmanuel, Patricia J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; VIRUS TRANSMISSION; WESTERN BLOTTING; ADOLESCENT; ANALYTICAL EQUIPMENT; CHILD; DIAGNOSIS, MEASUREMENT AND ANALYSIS; FLUORESCENT ANTIBODY TECHNIQUE; INFANT; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

VIRUS DNA;

ADOLESCENT; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HIV INFECTIONS; HUMANS; INFANT; LABORATORY TECHNIQUES AND PROCEDURES; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34248589492     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.1080/15513810601123367     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention. Pneumocystis pneumonia: Los Angeles. Morb Mortal Wkly Rep 30:250-252, 1981.
2. Joint United Nations Programme on HIV/AIDS and the World Health Organization. AIDS Epidemic Update - December 2005. Geneva, Switzerland: UNAIDS Publication, 2005.
3. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2004. 16:1-46, 2005.
4. Mofenson LM. American Academy of Pediatrics, Committee on Pediatric AIDS. Technical report: perinatal human immunodeficiency virus testing and prevention of transmission. Pediatrics 106:e88, 2000.
5. King SM. American academy of pediatrics, committee on pediatric AIDS. Evaluation and treatment of the human immunodeficiency virus-1 - exposed infant. Pediatrics 114:497-505, 2004.
6. Zaman MM, Recco RA, Haag R. Infection with non-B subtype HIV type 1 complicates management of established infection in adult patients and diagnosis of infection in newborn infants. Clin Infect Dis 34:417-418, 2002.
7. Nielsen K, Bryson YJ. Diagnosis of HIV infection in children. Pediatr Clin North Am 47:39-63, 2000.
8. Mylonakis E, Paliou M, Lally M, Flanigan TP, Rich JD. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med 109:568-576, 2000.
9. Kahn JO, Walker BD. Acute HIV infection. N Engl J Med 339:33-39, 1998.
10. Centers for Disease Control and Prevention. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. Morb Mortal Wkly Rep 38:1-7, 1989.
11. Bylund DJ, Ziegner UH, Hooper DG. Review of testing for human immunodeficiency virus. Clin Lab Med 12:305-333, 1992.
12. United States Food and Drug Administration. Testing yourself for HIV-1, the virus that causes AIDS. http://www.fda.gov/cber/infosheets/hiv-home2.htm. Accessed June 1, 2006.
13. Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 8:125-131, 2006.
14. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-1 testing during labor: a multicenter study. JAMA 292:219-223, 2004.
15. Keenan PA, Keenan JM, Branson BM. Rapid HIV testing. Wait time reduced from days to minutes. Postgrad Med 117:47-52, 2005.
16. Centers for Disease Control and Prevention. Protocols for confirmation of reactive rapid HIV tests. Morb Mortal Wkly Rep 53: 221-222, 2004.
17. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. Morb Mortal Wkly Rep 50:1-57, 2001.
18. U.S. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States, November 17,2005. http://www.aidsinfo.nih.gov/Guidelines. Accessed June 15, 2006.
19. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 9:F7-11, 1995.
20. Obaro SK, Losikoff P, Harwell J, Pugatch D. Failure of serial human immunodeficiency virus type 1 DNA polymerase chain reactions to identify human immunodeficiency virus type 1 clade A/G. Pediatr Infect Dis J 24:183-184, 2005.
21. Lujan-Zilbermann J, Bitar W, Knapp K, Flynn P. Human immunodeficiency virus type 1 RNA polymerase chain reaction reasonably excludes infection in exposed infants. Pediatr Infect Dis J 22:97-99, 2003.
22. Sun R, Ku J, Jayakar H, et al. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 36:2964-2969, 1998.
23. Vandamme AM, Van Dooren S, Kok W, et al. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods 52:121-132, 1995.
24. Kline NE, Schwarzwald H, Kline MW. False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus 1 infection. Pediatr Infect Dis J 21:885-886, 2002.
25. Shanmugam V, Switzer WM, Nkengasong JN, et al. Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections. J Acquir Immune Defic Syndr 24:257-263, 2000.
26. Gueudin M, Plantier JC, Damond F, et al. Plasma viral RNA assay in HIV-1 group O infection by real-time PCR. J Virol Methods 113:43-49, 2003.
27. Zhang M, Versalovic J. HIV update: diagnostic tests and markers of disease progression and response to therapy. Am J Clin Pathol 118 Suppl:S26-32, 2002.
28. Demeter LM, Bosch RJ, Coombs RW, et al. Detection of replication- competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter. J Clin Microbiol 40:2089-2094, 2002.
29. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group. J Infect Dis 170:996-1000, 1994.
30. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 327:1246-1247, 1992.